Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 495-42-1
2. (1r)-2-(methylamino)-1-phenylethanol
3. (1r)-2-(methylamino)-1-phenylethan-1-ol
4. Aih8flv35k
5. Halostachin
6. Unii-aih8flv35k
7. Halostachine [mi]
8. Halostachine, (-)-
9. Schembl932123
10. Benzenemethanol, Alpha-((methylamino)methyl)-, (r)-
11. (r)-(-)-halostachine
12. Chembl1160736
13. Niosh/do9650000
14. Dtxsid00879576
15. Chebi:167510
16. Zinc393338
17. (r)-2-methylamino-1-phenylethanol
18. (r)-2-(methylamino)-1-phenylethanol
19. Akos030584896
20. D-1-phenyl-1-oxy-2-(methylamino)-aethan
21. (-)-phenyl(methylaminomethyl)carbinol
22. Do96500000
23. (+)-alpha-((methylamino)methyl)benzyl Alcohol
24. Benzenemethanol, Alpha-((methylamino)methyl)-, D-
25. (-)-1-hydroxy-1-phenyl-2-methylaminoethane
26. D-1-phenyl-1-oxy-2-(methylamino)-aethan [german]
27. Q5643464
28. (-)-.alpha.-(methylaminomethyl)benzyl Alcohol
29. Benzyl Alcohol, Alpha-((methylamino)methyl)-, (+)-
30. F1909-1619
31. Benzenemethanol, .alpha.-((methylamino)methyl)-, (.alpha.r)-
| Molecular Weight | 151.21 g/mol |
|---|---|
| Molecular Formula | C9H13NO |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 151.099714038 g/mol |
| Monoisotopic Mass | 151.099714038 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 99.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Halostachine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halostachine, including repackagers and relabelers. The FDA regulates Halostachine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halostachine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Halostachine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Halostachine supplier is an individual or a company that provides Halostachine active pharmaceutical ingredient (API) or Halostachine finished formulations upon request. The Halostachine suppliers may include Halostachine API manufacturers, exporters, distributors and traders.
click here to find a list of Halostachine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Halostachine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Halostachine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halostachine GMP manufacturer or Halostachine GMP API supplier for your needs.
A Halostachine CoA (Certificate of Analysis) is a formal document that attests to Halostachine's compliance with Halostachine specifications and serves as a tool for batch-level quality control.
Halostachine CoA mostly includes findings from lab analyses of a specific batch. For each Halostachine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Halostachine may be tested according to a variety of international standards, such as European Pharmacopoeia (Halostachine EP), Halostachine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halostachine USP).
LOOKING FOR A SUPPLIER?
